Condition

Epstein-Barr Virus Infections clinical trials and research

• 6Clinical trials
• 4Countries

Newest Epstein-Barr Virus Infections clinical trials

All recruiting trials (6)

• Partially HLA-matched virus-specific T-cell therapy for adenovirus, CMV, or EBV in immunocompromised patients

  This will try partially matched virus-specific T cells to treat adenovirus, CMV, or EBV infections in people whose immune systems are weakened after stem-cell or organ transplants or other immunodeficiencies.

  Recruiting at 2 sites Phase 1/2 Stanford University · Palo Alto, California and 2 other locations · NCT06909110

• Treatment with STAR0602 for advanced solid tumors

  This study is testing a new treatment called STAR0602 to see if it can help people with advanced solid tumors by looking at how safe it is and how well it works.

  Recruiting at 16 sites Phase 1/2 Marengo Therapeutics, Inc. · Sacramento, California and 18 other locations · NCT05592626

• Treatment of viral infections using rapidly generated T cells

  This study is testing a new treatment using specially made T cells to help patients with weakened immune systems who are struggling with serious viral infections like Epstein-Barr or cytomegalovirus.

  Recruiting Phase 1 Columbia University · New York, New York · NCT05183490

• Using Rituximab to prevent Epstein-Barr Virus infection in kidney transplant patients

  This study is testing if a single dose of Rituximab can help prevent Epstein-Barr Virus infection in kidney transplant patients who are at risk for complications.

  Recruiting Phase 4 University Hospital, Strasbourg, France · Strasbourg · NCT04989491

• Using EBV-specific T-cells to treat difficult Epstein-Barr virus infections

  This study is testing a new treatment using specially made immune cells to help children and young adults who have tough Epstein-Barr virus infections after receiving organ transplants.

  Recruiting at 8 sites Phase 2 New York Medical College · Los Angeles, California and 7 other locations · NCT03266653

• Using Nivolumab to treat EBV-positive lymphoproliferative disorders and non-Hodgkin lymphomas

  This study is testing if a new drug called Nivolumab can help people aged 12 and older with certain types of lymphomas that are linked to the Epstein-Barr Virus and haven't improved with other treatments.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT03258567

Related topics

Quick answers

How many Epstein-Barr Virus Infections clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (5 trials), France (2 trials), Canada (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2: 2, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →